Montenegro vs Paraguay: Access to anti-retroviral drugs, male
Montenegro
61.0%
in 2024
Paraguay
61.0%
in 2024
Montenegro rank
97th
Paraguay rank
97th
Access to anti-retroviral drugs, male over time
- Montenegro
- Paraguay
How they compare
Montenegro currently reports 61.0% against 61.0% in Paraguay, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Montenegro ahead.
Montenegro ranks 97th and Paraguay ranks 97th of 141 countries.
Montenegro has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Montenegro | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.5% | 6.4% | 8.1% | Montenegro |
| 2010s | 36.8% | 34.0% | 2.8% | Montenegro |
| 2020s | 56.4% | 56.2% | 0.2% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Montenegro or Paraguay?
- Montenegro, at 61.0% against 61.0% in Paraguay as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Montenegro and Paraguay?
- 0.0%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do Montenegro and Paraguay rank globally for access to anti-retroviral drugs, male?
- Montenegro ranks 97th and Paraguay ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.